CHO Pharma, Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 138,000. Operating loss was TWD 174.423 million compared to TWD 172.987 million a year ago. Net loss was TWD 167.448 million compared to TWD 166.978 million a year ago. Basic loss per share was TWD 0.91 compared to TWD 0.91 a year ago.